Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. Campion SL, Brenna E, Thomson E, Fischer W, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Campion SL, Brenna E, Thomson E, Fischer W, et al. Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. J Clin Invest 2021;131.
PMID: 34850742